Is there any place for a wait-and-see policy in stage I0 follicular lymphoma? A study of 43 consecutive patients in a single center

Annals of Oncology

Volumn 7, Issue 7, 1996, Pages 713-718

  Soubeyran, P ^a   Eghbali, H ^a   Trojani, M ^a   Bonichon, F ^a   Richaud, P ^a   Hoerni B ^a  

^a INSTITUT BERGONIÉ   (France)

Author keywords

Follicular lymphoma; Limited stages; Wait and see policy

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; FEMALE; FOLLICULAR LYMPHOMA; HUMAN; MALE; PRIORITY JOURNAL;

EID: 0029840357     PISSN: 09237534     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.annonc.a010720     Document Type: Article

References (37)

1. Jaffe ES. Follicular lymphomas: Possibility that they are benign tumors of the lymphoid system. J Natl Cancer Inst 1983; 70: 401-3.
2. Hœrni B. Follicular lymphomas. J Eur Radiother 1985; 6: 121-8.
3. Macmanus MP, Hoppe RT. Is radiotherapy curative for stage I and II low-grade follicular lymphoma? Results of a long-term follow-up study of patients treated at Stanford University. J Clin Oncol 1996; 14: 1282-90.
4. McLaughlin P, Fuller LM, Velasquez WS et al. Stage I-II follicular lymphoma. Treatment results for 76 patients. Cancer 1986; 58: 1596-602.
5. Paryani SB, Hoppe RT, Cox RS et al. Analysis of non-Hodgkin's lymphomas with nodular and favorable histologies, stages I and II. Cancer 1983; 52: 2300-7.
6. Soubeyran P, Eghbali H, Bonichon F et al. Localized follicular lymphomas: Prognosis and survival of stages I and II in a retrospective series of 103 patients. Radiother Oncol 1988; 13: 91-8.
7. Horning SJ. Natural history of and therapy for the indolent non-Hodgkin's lymphomas. Semin Oncol 1993; 20: 75-88.
8. Horning SJ, Rosenberg SA. The natural history of initially untreated low-grade non-Hodgkin's lymphomas. N Engl J Med 1984; 311: 1471-5.
9. Portlock CS, Rosenberg SA. No initial therapy for stage III and IV non-Hodgkin's lymphomas of favorable histologic types. Ann Intern Med 1979; 90: 10-3.
10. Lennert K, Feller AC. Histopathology of Non-Hodgkin's Lymphomas. Berlin: Springer-Verlag 1992.
11. The non-Hodgkin's lymphoma pathologic classification project. National Cancer Institute sponsored study of classifications of non-Hodgkin's lymphomas. Cancer 1982; 49: 2112-35.
12. Denham JW, Denham E, Dear KB et al. The follicular non-Hodgkin's lymphomas. 2. Prognostic factors: What do they mean? Eur J Cancer 1996; 32A: 480-90.
13. Chauvergne J, Durand M, Hœrni B et al. Induction chemotherapy of non-Hodgkin's lymphomas. Preliminary results of a controlled trial. Eur J Cancer 1977; 13: 399-400.
14. Dixon DO, McLaughlin P, Hagemeister FB et al. Reporting outcomes in Hodgkin's disease and lymphoma. J Clin Oncol 1987; 5: 1670-2.
15. Soubeyran P, Bonichon F, Richaud P et al. Treatment of follicular lymphomas at limited stage III. Advantages of radiotherapy. J Eur Radiother 1987; 8: 61-6.
16. Coiffier B, Bastion Y, Berger F et al. Prognostic factors in follicular lymphomas. Semin Oncol 1993; 20: 89-95.
17. Soubeyran P, Bonichon F, Eghbali H et al. Relapses of follicular lymphomas. Prognosis and survival in a retrospective series of 92 patients and 129 relapses. J Eur Radiother 1989; 10: 65-76.
18. Lister TA. The management of follicular lymphoma. Ann Oncol 1991; 2 (Suppl 2): 131-5.
19. Landberg TG, Hakansson LG, Möller TR et al. CVP-remission-maintenance in stage I or II non-Hodgkin's lymphomas. Preliminary results of a randomized study. Cancer 1979; 44: 831-8.
20. Monfardini S, Banfi A. Bonadonna G et al. Improved five-year survival after combined radiotherapy-chemotherapy for stage I-II non-Hodgkin's lymphoma. Int J Radiat Oncol Biol Phys 1981; 6: 125-34.
21. Nissen NI, Ersboll J, Hansen HS et al. A randomized study of radiotherapy versus radiotherapy plus chemotherapy in stage I-II non-Hodgkin's lymphoma. Cancer 1983; 52: 1-7.
22. Solal Celigny P, Lepage E, Brousse N et al. Recombinant interferon alfa-2b combined with a regimen containing doxorubicin in patients with advanced follicular lymphoma. Groupe d'Étude des Lymphomes de l'Adulte. N Engl J Med 1993; 329: 1608-14.
23. Brice P, Solal Celigny P, Lepage E et al. A randomized study in low tumor burden follicular lymphoma between no treatment, prednimustine and interferon. J Clin Oncol 1995; 14: 394.
24. Meerwaldt JH, Carde P, Burgers JM et al. Low-dose total body irradiation versus combination chemotherapy for lymphomas with follicular growth pattern. Int J Radiat Oncol Biol Phys 1991; 21: 1167-72.
25. Richaud P, Hœrni-Simon G, Denépoux R et al. Total body irradiation (TBI). Preliminary results of a new technique used in 30 patients with hematologic malignancies. Strahlenther Onkol 1979; 155: 736-9.
26. Gribben JG. Attainment of molecular remission: A worthwhile goal? J Clin Oncol 1994; 12: 1532-4.
27. Sklar J. Polymerase chain reaction: The molecular microscope of residual disease. J Clin Oncol 1991; 9: 1521-4.
28. Gribben JG, Freedman As, Woo SD et al. All advanced stage non-Hodgkin's lymphomas with a polymerase chain reaction amplifiable breakpoint of bcl-2 have residual cells containing the bcl-2 rearrangement at evaluation and after treatment. Blood 1991; 78: 3275-80.
29. Lee MS, Chang KS, Cabanillas F et al. Detection of minimal residual cells carrying the t(14;18) by DNA sequence amplification. Science 1987; 237: 175-8.
30. Meijerink JP, Smetsers TF, Raemaekers JM et al. Quantitation of follicular non-Hodgkin's lymphoma cells carrying t(14;18) by competitive polymerase chain reaction. Br J Haematol 1993; 84: 250-6.
31. Soubeyran P, Cabanillas F, Lee MS. Analysis of the expression of the hybrid gene bcl-2/IgH in follicular lymphomas. Blood 1993; 81: 122-7.
32. Gribben JG, Neuberg D, Freedman AS et al. Detection by polymerase chain reaction of residual cells with the bcl-2 translocation is associated with increased risk of relapse after autologous bone marrow transplantation for B-cell lymphoma. Blood 1993; 81: 3449-57.
33. Johnson PW, Price CG, Smith T et al. Detection of cells bearing the t(14;18) translocation following myeloablative treatment and autologous bone marrow transplantation for follicular lymphoma. J Clin Oncol 1994; 12: 798-805.
34. Negrin RS, Pesando J. Detection of tumor cells in purged bone marrow and peripheral-blood mononuclear cells by polymerase. J Clin Oncol 1994; 12: 1021-7.
35. Price CG, Meerabux J, Murtagh S et al. The significance of circulating cells carrying t(14;18) in long remission from follicular lymphoma. J Clin Oncol 1991; 9: 1527-32.
36. Campana D, Pui CH. Detection of minimal residual disease in acute leukemia: Methodological advances and clinical significance. Blood 1995; 85: 1416-34.
37. Soubeyran P, Eghbali H, Bonichon F et al. Low-grade follicular lymphomas: Analysis of prognosis in a series of 281 patients. Eur J Cancer 1991; 27: 1606-13.